Cell-type-specific and high-resolution profiling of postsynaptic proteomes altered in Alzheimer's disease model mice
阿尔茨海默病模型小鼠突触后蛋白质组的细胞类型特异性和高分辨率分析
基本信息
- 批准号:10045381
- 负责人:
- 金额:$ 42.35万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2020
- 资助国家:美国
- 起止时间:2020-08-01 至 2023-07-31
- 项目状态:已结题
- 来源:
- 关键词:Alzheimer&aposs DiseaseAlzheimer&aposs disease brainAlzheimer&aposs disease modelAlzheimer&aposs disease pathologyAlzheimer&aposs disease patientAmyloid beta-ProteinBiochemicalBrainDementiaDependovirusDepositionDevelopmentElectrophysiology (science)Enterobacteria phage P1 Cre recombinaseFaceFailureFunctional disorderGoalsHealthHealth Care CostsHeterogeneityHippocampus (Brain)ImpairmentIntrabodyLong-Term PotentiationMapsMemoryMemory LossMemory impairmentMethodsMicroscopyMissionMolecularMusMutationNeurodegenerative DisordersNeurofibrillary TanglesNeuronsPathogenesisPathologicPopulationProteinsProteomeProteomicsPublic HealthRecombinant AntibodyRecording of previous eventsResearchResolutionSenile PlaquesSpecimenSynapsesSynaptic TransmissionSynaptic plasticitySystems DevelopmentTechniquesTissue ExpansionUnited States National Institutes of Healthbasebrain tissuecalmodulin-dependent protein kinase IIcell typecognitive functionexcitatory neuronfamilial Alzheimer diseaseinnovationmemory recallmethod developmentmolecular dynamicsmouse modelneuron lossneuropathologypostsynapticrecombinasespatiotemporaltherapeutic targettransgenic model of alzheimer disease
项目摘要
PROJECT SUMMARY/ABSTRACT
Alzheimer's disease (AD) is the most common cause of dementia with progressive loss of memory and cognitive
functions. In several AD model mice, the deficits in memory and cognitive functions are highly correlated with an
impairment in basal synaptic transmission and synaptic plasticity. Intriguingly, many of the AD model mice show
significant deficits in synaptic transmission and plasticity before the development of b-amyloid deposits, which is
a typical hallmark of AD pathology. Thus, synaptic dysfunction is a potentially important component of AD
pathogenesis. However, to understand the synaptic dysfunction in AD at molecular levels, we face a significant
obstacle, which is heterogeneity at multiple levels, due to neuronal heterogeneity and synaptic history (synaptic
plasticity). There is, therefore, a critical need to develop a biochemical method that can analyze synaptic
molecular constituents in a spatiotemporal manner to understand in substance the synaptic molecular alterations
involved in AD.
Here, the overall objective in this application is the development of systems-type biochemical methods that
enable cell-type-specific and high-resolution profiling of postsynaptic proteomes. The rationale for this project is
that these method developments are likely to advance the isolation of molecularly homogeneous postsynaptic
proteomes, which will ultimately provide more substantive maps of synaptic protein changes that contribute to
the synaptic dysfunction seen in AD.
To attain the overall objectives, the following two specific aims will be pursued: 1) Develop cell-type-specific
profiling methods of postsynaptic proteomes using Cre recombinase-dependent strategies; and 2) Develop high-
resolution profiling methods to identify sub-synaptic proteomes. This innovation in postsynaptic proteomics is
expected to allow us to isolate postsynaptic proteomes from the defined population of synapses and sub-synaptic
domains in AD model mice. More substantive profiles of synaptic molecular alterations in AD model mice will
provide a significant advance in the understanding of synaptic dysfunction in AD at molecular levels and new
opportunities for discovering therapeutic targets of AD.
项目总结/文摘
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
NMDA receptor-targeted enrichment of CaMKIIα improves fear memory.
- DOI:10.1016/j.isci.2022.104864
- 发表时间:2022-08-19
- 期刊:
- 影响因子:5.8
- 作者:Chifor, Anthony;Choi, Jeongyoon;Park, Joongkyu
- 通讯作者:Park, Joongkyu
Chemogenetic regulation of the TARP-lipid interaction mimics LTP and reversibly modifies behavior.
- DOI:10.1016/j.celrep.2023.112826
- 发表时间:2023-08-29
- 期刊:
- 影响因子:8.8
- 作者:
- 通讯作者:
The Troyer syndrome protein spartin mediates selective autophagy of lipid droplets.
- DOI:10.1038/s41556-023-01178-w
- 发表时间:2023-08
- 期刊:
- 影响因子:21.3
- 作者:
- 通讯作者:
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joongkyu Park其他文献
Joongkyu Park的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
新型F-18标记香豆素衍生物PET探针的研制及靶向Alzheimer's Disease 斑块显像研究
- 批准号:81000622
- 批准年份:2010
- 资助金额:20.0 万元
- 项目类别:青年科学基金项目
阿尔茨海默病(Alzheimer's disease,AD)动物模型构建的分子机理研究
- 批准号:31060293
- 批准年份:2010
- 资助金额:26.0 万元
- 项目类别:地区科学基金项目
跨膜转运蛋白21(TMP21)对引起阿尔茨海默病(Alzheimer'S Disease)的γ分泌酶的作用研究
- 批准号:30960334
- 批准年份:2009
- 资助金额:22.0 万元
- 项目类别:地区科学基金项目
相似海外基金
Pathophysiological mechanisms of hypoperfusion in mouse models of Alzheimer?s disease and small vessel disease
阿尔茨海默病和小血管疾病小鼠模型低灌注的病理生理机制
- 批准号:
10657993 - 财政年份:2023
- 资助金额:
$ 42.35万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10381163 - 财政年份:2022
- 资助金额:
$ 42.35万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10531959 - 财政年份:2022
- 资助金额:
$ 42.35万 - 项目类别:
The Role of Menopause-Driven DNA Damage and Epigenetic Dysregulation in Alzheimer s Disease
更年期驱动的 DNA 损伤和表观遗传失调在阿尔茨海默病中的作用
- 批准号:
10700991 - 财政年份:2022
- 资助金额:
$ 42.35万 - 项目类别:
Interneurons as early drivers of Huntington´s disease progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10518582 - 财政年份:2022
- 资助金额:
$ 42.35万 - 项目类别:
Interneurons as Early Drivers of Huntington´s Disease Progression
中间神经元是亨廷顿病进展的早期驱动因素
- 批准号:
10672973 - 财政年份:2022
- 资助金额:
$ 42.35万 - 项目类别:
Social Connectedness and Communication in Parents with Huntington''s Disease and their Offspring: Associations with Psychological and Disease Progression
患有亨廷顿病的父母及其后代的社会联系和沟通:与心理和疾病进展的关联
- 批准号:
10585925 - 财政年份:2022
- 资助金额:
$ 42.35万 - 项目类别:
Oligodendrocyte heterogeneity in Alzheimer' s disease
阿尔茨海默病中的少突胶质细胞异质性
- 批准号:
10180000 - 财政年份:2021
- 资助金额:
$ 42.35万 - 项目类别:
Serum proteome analysis of Alzheimer´s disease in a population-based longitudinal cohort study - the AGES Reykjavik study
基于人群的纵向队列研究中阿尔茨海默病的血清蛋白质组分析 - AGES 雷克雅未克研究
- 批准号:
10049426 - 财政年份:2021
- 资助金额:
$ 42.35万 - 项目类别:
Repurposing drugs for Alzheimer´s disease using a reverse translational approach
使用逆翻译方法重新利用治疗阿尔茨海默病的药物
- 批准号:
10295809 - 财政年份:2021
- 资助金额:
$ 42.35万 - 项目类别:














{{item.name}}会员




